EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6371-6380

  Xu, Xiangbin ^a   Woo, Chang Hoon ^b,c   Steere, Rachel R ^a   Lee, Byung Cheol ^b   Huang, Yuxian ^a,d   Wu, Jing ^a,d   Pang, Jinjiang ^a   Lim, Jae Hyang ^a,b   Xu, Haidong ^a,b   Zhang, Wenhong ^d   Konduru, Anuhya S ^b   Yan, Chen ^a   Cheeseman, Michael T ^e   Brown, Steve D M ^e   Li, Jian Dong ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c Yeungnam University College of Medicine   (South Korea)

^d FUDAN UNIVERSITY   (China)

^e MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; ZINC FINGER PROTEIN;

ACETYLATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA BINDING; ECOTROPIC VIRAL INTEGRATION SITE; ECOTROPIC VIRUS; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMOGENESIS; MOLECULAR MECHANICS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SUBUNIT; PROTO ONCOGENE;

ACETYLATION; ANIMALS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEEDBACK, PHYSIOLOGICAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; IMMUNOPRECIPITATION; INFLAMMATION; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; PROTO-ONCOGENES; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862627867     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103527     Document Type: Article

References (58)

1. Morishita, K., D. S. Parker, M. L. Mucenski, N. A. Jenkins, N. G. Copeland, and J. N. Ihle. 1988. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54: 831-840.
2. Morishita, K., E. Parganas, C. L. William, M. H. Whittaker, H. Drabkin, J. Oval, R. Taetle, M. B. Valentine, and J. N. Ihle. 1992. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA 89: 3937-3941.
3. Mitani, K., S. Ogawa, T. Tanaka, H. Miyoshi, M. Kurokawa, H. Mano, Y. Yazaki, M. Ohki, and H. Hirai. 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13: 504-510.
4. Lugthart, S., E. van Drunen, Y. van Norden, A. van Hoven, C. A. Erpelinck, P. J. Valk, H. B. Beverloo, B. Löwenberg, and R. Delwel. 2008. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 over-expression and chromosome 3q26 abnormalities underestimated. Blood 111: 4329-4337.
5. Alessandrino, E. P., S. Amadori, M. Cazzola, F. Locatelli, C. Mecucci, E. Morra, G. Saglio, G. Visani, and S. Tura. 2001. Myelodysplastic syndromes: recent advances. Haematologica 86: 1124-1157. (Pubitemid 33063860)
6. Yatsula, B., S. Lin, A. J. Read, A. Poholek, K. Yates, D. Yue, P. Hui, and A. S. Perkins. 2005. Identification of binding sites of EVI1 in mammalian cells. J. Biol. Chem. 280: 30712-30722. (Pubitemid 41291800)
7. Morishita, K., K. Suzukawa, T. Taki, J. N. Ihle, and J. Yokota. 1995. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC. Oncogene 10: 1961-1967.
8. Delwel, R., T. Funabiki, B. L. Kreider, K. Morishita, and J. N. Ihle. 1993. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. Mol. Cell. Biol. 13: 4291-4300. (Pubitemid 23187658)
9. Perkins, A. S., R. Fishel, N. A. Jenkins, and N. G. Copeland. 1991. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol. Cell. Biol. 11: 2665-2674. (Pubitemid 21895646)
10. Palmer, S., J. P. Brouillet, A. Kilbey, R. Fulton, M. Walker, M. Crossley, and C. Bartholomew. 2001. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J. Biol. Chem. 276: 25834-25840.
11. Turner, J., and M. Crossley. 1998. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulators. EMBO J. 17: 5129-5140. (Pubitemid 28408479)
12. Chakraborty, S., V. Senyuk, S. Sitailo, Y. Chi, and G. Nucifora. 2001. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles. J. Biol. Chem. 276: 44936-44943.
13. Parkinson, N., R. E. Hardisty-Hughes, H. Tateossian, H. T. Tsai, D. Brooker, S. Morse, Z. Lalane, F. MacKenzie, M. Fray, P. Glenister, et al. 2006. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet. 2: e149.
14. Tetley, T. D. 2005. Inflammatory cells and chronic obstructive pulmonary disease. Curr. Drug Targets Inflamm. Allergy 4: 607-618. (Pubitemid 41722371)
15. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420: 868-874. (Pubitemid 36019640)
16. Kleiman, A., and J. P. Tuckermann. 2007. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol. Cell. Endocrinol. 275: 98-108. (Pubitemid 47259279)
17. Manson, S. C., R. E. Brown, A. Cerulli, and C. F. Vidaurre. 2009. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir. Med. 103: 975-994.
18. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852. (Pubitemid 36019637)
19. Rothwarf, D. M., and M. Karin. 1999. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE 1999: RE1.
20. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866. (Pubitemid 27467923)
21. Régnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IkappaB kinase. Cell 90: 373-383.
22. Jacobs, M. D., and S. C. Harrison. 1998. Structure of an IkappaBalpha/NF-kappaB complex. Cell 95: 749-758.
23. Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18: 6867-6874.
24. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21: 6539-6548. (Pubitemid 35448431)
25. Kiernan, R., V. Brès, R. W. Ng, M. P. Coudart, S. El Messaoudi, C. Sardet, D. Y. Jin, S. Emiliani, and M. Benkirane. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278: 2758-2766. (Pubitemid 36801357)
26. Hoberg, J. E., A. E. Popko, C. S. Ramsey, and M. W. Mayo. 2006. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/ p65 by p300. Mol. Cell. Biol. 26: 457-471. (Pubitemid 43090920)
27. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959. (Pubitemid 26404293)
28. Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19: 1176-1179. (Pubitemid 30151013)
29. Shimahara, A., N. Yamakawa, I. Nishikata, and K. Morishita. 2010. Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2. J. Biol. Chem. 285: 16967-16977.
30. Kuklinska, D., and M. Kilian. 1984. Relative proportions of Haemophilus species in the throat of healthy children and adults. Eur. J. Clin. Microbiol. 3: 249-252. (Pubitemid 14064354)
31. Murphy, T. F. 2000. Bacterial otitis media: pathogenetic considerations. Pediatr. Infect. Dis. J. 19: S9-15; discussion S15-16.
32. Bluestone, C. D. 1982. Otitis media in children: to treat or not to treat? N. Engl. J. Med. 306: 1399-1404.
33. Foxwell, A. R., J. M. Kyd, and A. W. Cripps. 1998. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol. Mol. Biol. Rev. 62: 294-308. (Pubitemid 28270276)
34. Murphy, T. F., and S. Sethi. 1992. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 146: 1067-1083.
35. Murphy, T. F. 2006. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr. Opin. Infect. Dis. 19: 225-230. (Pubitemid 43740359)
36. Watanabe, T., H. Jono, J. Han, D. J. Lim, and J. D. Li. 2004. Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 101: 3563-3568. (Pubitemid 38338235)
37. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl.): S81-S96.
38. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
39. Hrabé de Angelis, M. H., H. Flaswinkel, H. Fuchs, B. Rathkolb, D. Soewarto, S. Marschall, S. Heffner, W. Pargent, K. Wuensch, M. Jung, et al. 2000. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25: 444-447. (Pubitemid 32983440)
40. Nolan, P. M., J. Peters, M. Strivens, D. Rogers, J. Hagan, N. Spurr, I. C. Gray, L. Vizor, D. Brooker, E. Whitehill, et al. 2000. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25: 440-443. (Pubitemid 32983439)
41. Jeon, K. I., X. Xu, T. Aizawa, J. H. Lim, H. Jono, D. S. Kwon, J. Abe, B. C. Berk, J. D. Li, and C. Yan. 2010. Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc. Natl. Acad. Sci. USA 107: 9795-9800.
42. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98: 8774-8779. (Pubitemid 32678103)
43. Lim, J. H., H. J. Kim, K. Komatsu, U. Ha, Y. Huang, H. Jono, S. M. Kweon, J. Lee, X. Xu, G. S. Zhang, et al. 2009. Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways. Am. J. Transl. Res. 1: 300-311.
44. Komatsu, K., H. Jono, J. H. Lim, A. Imasato, H. Xu, H. Kai, C. Yan, and J. D. Li. 2008. Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced MUC5AC mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. Biochem. Biophys. Res. Commun. 377: 763-768.
45. Ishinaga, H., H. Jono, J. H. Lim, S. M. Kweon, H. Xu, U. H. Ha, H. Xu, T. Koga, C. Yan, X. H. Feng, et al. 2007. TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J. 26: 1150-1162.
46. Xu, X., C. H. Ha, C. Wong, W. Wang, A. Hausser, K. Pfizenmaier, E. N. Olson, T. A. McKinsey, and Z. G. Jin. 2007. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27: 2355-2362. (Pubitemid 350203950)
47. Xu, X., B. S. Jhun, C. H. Ha, and Z. G. Jin. 2008. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 149: 4183-4192.
48. Raskatov, J. A., J. L. Meier, J. W. Puckett, F. Yang, P. Ramakrishnan, and P. B. Dervan. 2012. Modulation of NF-kB-dependent gene transcription using programmable DNA minor groove binders. Proc. Natl. Acad. Sci. USA 109: 1023-1028.
49. Rana, S. N., X. Li, I. H. Chaudry, K. I. Bland, and M. A. Choudhry. 2005. Inhibition of IL-18 reduces myeloperoxidase activity and prevents edema in intestine following alcohol and burn injury. J. Leukoc. Biol. 77: 719-728. (Pubitemid 40628752)
50. Yu, H. P., S. Yang, Y. C. Hsieh, M. A. Choudhry, K. I. Bland, and I. H. Chaudry. 2006. Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: upregulation of heme oxygenase-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L400-L406. (Pubitemid 44343716)
51. Chen, L. F., S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Greene. 2005. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25: 7966-7975. (Pubitemid 41262991)
52. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
53. Barjesteh van Waalwijk van Doorn-Khosrovani, S., C. Erpelinck, W. L. van Putten, P. J. Valk, S. van der Poel-van de Luytgaarde, R. Hack, R. Slater, E. M. Smit, H. B. Beverloo, G. Verhoef, et al. 2003. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101: 837-845.
54. Kurokawa, M., K. Mitani, K. Irie, T. Matsuyama, T. Takahashi, S. Chiba, Y. Yazaki, K. Matsumoto, and H. Hirai. 1998. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature 394: 92-96. (Pubitemid 28321809)
55. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5: 392-401.
56. Bonizzi, G., and M. Karin. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288. (Pubitemid 38610351)
57. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101: 1315-1320. (Pubitemid 38182686)
58. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13: 437-457.